Contact

Contact person:

CEO: Edwin Klumper
PHONE: –
E-MAIL: edwin.klumper@lytixbiopharma.com
WEB SITE: www.lytixbiopharma.com

About

Founded in: 2003

Number of employees: 15

CEO: Edwin Klumper

COMPANY DESCRIPTION:

Lytix Biopharma’s technology is based on nature’s own defense mechanism – the membranes of bacteria and cancer cells are destroyed. Our technology has the potential to meet two substantial medical challenges; cancer therapy that increase patient specific immune response to cancer and treatment of infections regardless of resistance. Lytix Biopharma’s strategy is to develop its drug candidates through Phase II, and then collaborate with partners for the final stages of product development and commercialization.